Clinical trial
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
NCT03828019 is registered in ClinicalTrials.gov with JHSPH Center for Clinical Trials as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
- Lead sponsor
- JHSPH Center for Clinical Trials
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 16, 2019
- Completion date
- September 9, 2024
- Enrollment
- 227 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.